Keytruda (pembrolizumab, Merck & Co) was just FDA-approved to treat patients with advanced (metastatic) NSCLC with tumors that express a protein called PD-L1, according to an agency news release.
A vitamin D deficiency may speed the progression of COPD, according to research.
Researchers show that pre- and post-natal exposure to tobacco is associated with a risk of behavioral disorders in children.
Lung transplant patients in Europe who live near busy roads with high air pollution are more likely to experience chronic organ rejection or die, according to new research.
The retired chairman and CEO of Hasbro will donate $12.5 million to Brown University to create an institute devoted to combating childhood asthma, autism, and obesity.
GlaxoSmithKline and Theravance have announced their intent to file a new drug application in Japan for Relvar Ellipta, a combination inhaler for COPD.
The interaction between infections and microbiota in the lungs during infancy could help provide clues to disease development later in life, according to ERS2015 research.
In a new study, a comparative analysis of the efficacy of Anoro Ellipta showed that it was as effective as other available dual-bronchodilator combinations for treating COPD.
A flu vaccination will be administered in tandem to identical twin astronauts Scott and Mark Kelly as part of NASA’s Twins Study.
PRAXIS is an interactive online community designed to support COPD caregivers and administrators to prevent and reduce hospital admissions and readmissions by improving care across the COPD care continuum.
A study completed at Boston Children’s Hospital reveals that children with pneumonia have an increased risk of developed COPD and decreased lung-function.
A group of Portuguese researchers has found significant differences in clinical particularities and survival between smokers and non-smokers who develop NSCLC.
For the first time, European researchers have succeeded in defining three distinct types of severe asthma by analyzing patient sputum samples, according to research presented at ERS 2015.
The findings, presented at ERS 2015, could speed up current diagnosis times for the disease and uncover COPD before serious exacerbations and further loss of lung function have occurred.
New York City’s second outbreak of Legionnaires’ disease in less than a year claimed its first victim, and has hospitalized 11.
Grandchildren's asthma risks increased from 10 to 22% if their grandmothers smoked while pregnant, even if their mothers had not.
An investigational inhaled drug for COPD inhibited neutrophil enhancement and inflammatory cytokine release in a small clinical study, according to research presented at ERS 2015.
A pooled analysis from three phase III studies show a 38% reduction in risk of death after up to two years on Esbriet treatment.
With the Improving Access to Clinical Trials Act (IACT) of 2009 set to expire on October 5, 2015, the Cystic Fibrosis Foundation championed a new bill to make the IACT legislation permanent.
The drug VIS410, being developed by Visterra Inc, targets a part of the influenza virus that is common to a wide range of flu strains.